Rockefeller Capital Management’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-105
| Closed | -$1K | – | 3496 |
|
|
2022
Q4 | $1K | Hold |
105
| – | – | ﹤0.01% | 3742 |
|
|
2022
Q3 | $1K | Hold |
105
| – | – | ﹤0.01% | 3773 |
|
|
2022
Q2 | $1K | Hold |
105
| – | – | ﹤0.01% | 4001 |
|
|
2022
Q1 | $3K | Sell |
105
-100
| -49% | -$2.86K | ﹤0.01% | 3524 |
|
|
2021
Q4 | $5K | Sell |
205
-37
| -15% | -$902 | ﹤0.01% | 3287 |
|
|
2021
Q3 | $8K | Sell |
242
-50
| -17% | -$1.65K | ﹤0.01% | 3002 |
|
|
2021
Q2 | $12K | Hold |
292
| – | – | ﹤0.01% | 2715 |
|
|
2021
Q1 | $9K | Buy |
292
+142
| +95% | +$4.38K | ﹤0.01% | 2651 |
|
|
2020
Q4 | $5K | Hold |
150
| – | – | ﹤0.01% | 2446 |
|
|
2020
Q3 | $3K | Hold |
150
| – | – | ﹤0.01% | 2361 |
|
|
2020
Q2 | $3K | Hold |
150
| – | – | ﹤0.01% | 2250 |
|
|
2020
Q1 | $2K | Hold |
150
| – | – | ﹤0.01% | 2208 |
|
|
2019
Q4 | $3K | Hold |
150
| – | – | ﹤0.01% | 1878 |
|
|
2019
Q3 | $3K | Buy |
+150
| New | +$3K | ﹤0.01% | 1742 |
|